Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 August 2019 | Story Lacea Loader

The composition of the UFS Council is stipulated in the UFS Statute, which was published in the Government Gazette on 26 January 2018 and amended by publication in the Government Gazette on 29 March 2019.

The Convocation has to elect two (2) external (neither employees nor students of UFS) representatives to the Council to represent the Convocation and Alumni on Council, following the expiry of the term of office of these representatives.  The two (2) elected representatives will serve for a period of four years on Council.

The Convocation comprises all persons who obtained a formal qualification from the UFS, as well as all permanent academic staff members.

Members of the Convocation are invited to submit written nominations by using the Nomination Form, for the following:

1.    one representative from the Qwaqwa Campus; and
2.    one other representative.

Every nomination form shall be signed by 4 (four) members of the Convocation and shall contain the written acceptance of the nomination by the nominee under his/her signature, as well as an abridged CV and a motivation of ± 200 words.

All nominations must reach the office of the Registrar no later than 16:30 on Tuesday, 17 September 2019.

If more than one person is nominated for each of the categories mentioned above, elections will be held as stipulated in the Institutional Rules. More information regarding this process will follow at that stage.

Nominations are to be submitted to:
e-mail: registrar@ufs.ac.za

or by post (strongly advised not to use this method due to delays):

Mr NN Ntsababa  
Registrar
University of the Free State
PO Box 339
Bloemfontein
9300

or hand-delivered to:                

Mr NN Ntsababa
Room 51, 1st Floor
Main Building
UFS Bloemfontein Campus

For enquiries, please contact Mr NN Ntsababa at registrar@ufs.ac.za or +27 51 401 3796.

Kindly take note that late or incomplete nominations will not be accepted or considered.

Every nomination must be submitted separately.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept